Business Wire (Tue, 15-Sep 8:00 AM ET)
Business Wire (Mon, 14-Sep 9:25 AM ET)
Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine
Business Wire (Wed, 2-Sep 8:00 AM ET)
Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
Business Wire (Thu, 27-Aug 8:00 AM ET)
Ardent Health Reports Second Quarter 2026 Results
Business Wire (Tue, 4-Aug 4:15 PM ET)
Ardent Health surpasses 1 million patient encounters supported by ambient AI
Business Wire (Thu, 23-Jul 8:00 AM ET)
Business Wire (Thu, 23-Jul 7:00 AM ET)
Ardent Health Announces Second Quarter 2026 Results Conference Call and Webcast Date
Business Wire (Fri, 17-Jul 8:00 AM ET)
Ardent Health Draws Investor Attention Ahead of Key Goldman Sachs Healthcare Conference
Market Chameleon (Thu, 4-Jun 7:09 AM ET)
Ardent Health Grows Adjusted EBITDA by 46% in Q3, But Guidance Reflects Rising Industry Pressures
Market Chameleon (Thu, 13-Nov 2:06 AM ET)
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.
Ardent Health trades on the NYSE stock market under the symbol ARDT.
As of September 17, 2026, ARDT stock price climbed to $10.81 with 57,776 million shares trading.
ARDT has a beta of 0.72, meaning it tends to be less sensitive to market movements. ARDT has a correlation of 0.02 to the broad based SPY ETF.
ARDT has a market cap of $1.52 billion. This is considered a Small Cap stock.
Last quarter Ardent Health reported $2 billion in Revenue and $.12 earnings per share. This fell short of revenue expectation by $-8 million and missed earnings estimates by -$.10.
The top ETF exchange traded funds that ARDT belongs to (by Net Assets): VTI, IWM, AVUV, BSVO, FYX.
ARDT has underperformed the market in the last year with a price return of -16.0% while the SPY ETF gained +16.6%. However, in the short term, ARDT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +16.7% vs +1.8% return in SPY. But in the last 2 weeks, ARDT shares have been beat by the market, returning -0.9% compared to an SPY return of -0.4%.
ARDT support price is $10.40 and resistance is $11.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARDT shares will trade within this expected range on the day.